Thiocolchicoside a semi-synthetic derivative of the Glory Lily: a new weapon to fight metastatic bone resorption? - Archive ouverte HAL Access content directly
Journal Articles British Journal of Pharmacology Year : 2012

Thiocolchicoside a semi-synthetic derivative of the Glory Lily: a new weapon to fight metastatic bone resorption?

(1) , (1) , (2)
1
2
Florent Dufour
Henning Walczak
  • Function : Author
  • PersonId : 903915

Abstract

Metastatic bone disease is a serious clinical complication for the treatment of patients with advanced cancer, but few therapeutic options are currently available. Bisphosphonates are an established standard care for these patients, but new treatments are now emerging, including the use of monoclonal antibodies targeting the RANK ligand. In this issue of the BJP, Reuter et al. provide evidence that thiocolchicoside, a semi-synthetic derivative of the naturally occurring colchicoside, extracted from the seeds of Gloriosa superba (Liliaceae), prevented osteoclactogenesis by suppressing RANK ligand-mediated NF-κB activation. Thiolcolchicoside may thus represent an attractive therapeutic option for the management of bone metastatic disease.
Fichier principal
Vignette du fichier
Brit_J_Pharmacol_Micheau_final.pdf (190.58 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00823463 , version 1 (17-05-2013)

Identifiers

Cite

Olivier Micheau, Florent Dufour, Henning Walczak. Thiocolchicoside a semi-synthetic derivative of the Glory Lily: a new weapon to fight metastatic bone resorption?: Thiocolchicoside to treat metastatic bone. British Journal of Pharmacology, 2012, 165 (7), pp.2124-6. ⟨10.1111/j.1476-5381.2011.01792.x⟩. ⟨inserm-00823463⟩
139 View
579 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More